Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
1.
Rev. bras. enferm ; 68(2): 219-227, Mar-Apr/2015. tab
Artículo en Español | LILACS, BDENF | ID: lil-752507

RESUMEN

RESUMEN Objetivo: estudio cualitativo que siguió los principios de la teoría fundamentada con el fin de analizar la identidad profesional de docentes de enfermería por medio del análisis de incidentes críticos que más las desestabilizaban. Método: entrevistas semi-estructuradas fueron realizadas a siete enfermeras que actúan como docentes e investigadoras en una universidad privada de Barcelona. Resultados: el material empírico resultante fue organizado en dos categorías: caracterización de los incidentes críticos y reacción de las enfermeras frente a ellos. Conclusión: se concluye que la identidad profesional de estas enfermeras en el campo académico está aún en construcción y que la inexperiencia es el mayor obstáculo que enfrentan para gestionar los incidentes críticos en el trabajo docente. .


RESUMO Objetivo: estudo qualitativo que seguiu os princípios da teoria fundamentada em dados com o objetivo de analisar a identidade profissional de docentes de enfermagem por meio da análise de incidentes críticos que mais as desestabilizaram. Método: entrevistas semiestruturadas foram realizadas com sete enfermeiras que atuam como docentes e pesquisadoras em uma universidade privada de Barcelona. Resultados: o material empírico resultante foi organizado em duas categorias: caracterização dos incidentes críticos e reação das enfermeiras frente a eles. Conclusão: concluiu-se que identidade profissional dessas enfermeiras no campo acadêmico está ainda em construção e a que inexperiência é o maior obstáculo que enfrentam para gerenciar incidentes críticos no trabalho docente. .


ABSTRACT Objective: a qualitative study that followed the principles of the grounded theory in order to analyze the professional identity of nursing academics through the analysis of the most disturbing critical incidents. Method: semi-structured interviews were conducted with seven nurses who worked as professors and researchers in a private university in Barcelona. Results: the resulting empirical material was organized into two categories: characterization of critical incidents and responsiveness to the incident. Conclusion: the professional identity of nurses regarding the academic area is still under construction and inexperience is the major obstacle in the management of critical incidents in the teaching career. .


Asunto(s)
Humanos , ADN , Receptores de Glucocorticoides/química , Receptores de Mineralocorticoides/química , Secuencia de Aminoácidos , Cristalografía por Rayos X , ADN , Escherichia coli/genética , Escherichia coli/metabolismo , Expresión Génica , Datos de Secuencia Molecular , Mutación , Neoplasias/genética , Neoplasias/metabolismo , Neoplasias/patología , Estructura Secundaria de Proteína , Estructura Terciaria de Proteína , Seudohipoaldosteronismo/genética , Seudohipoaldosteronismo/metabolismo , Seudohipoaldosteronismo/patología , Receptores de Glucocorticoides/genética , Receptores de Glucocorticoides/metabolismo , Receptores de Mineralocorticoides/genética , Receptores de Mineralocorticoides/metabolismo , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Alineación de Secuencia , Homología Estructural de Proteína
2.
Rev. panam. salud pública ; 36(5): 336-341, nov. 2014. graf, tab
Artículo en Español | LILACS | ID: lil-733237

RESUMEN

La epidemia de chikungunya en la República Dominicana se inició en febrero de 2014. En los primeros seis meses se registraron 429 421 casos, que representaron 65% de todos los notificados a la Organización Panamericana de la Salud por 33 países y territorios de la Región de las Américas. Esta epidemia se ha transmitido con rapidez en dicho país y ha demandado una intensa respuesta intersectorial, que ha liderado el Ministerio de Salud Pública y, especialmente, el Sistema Nacional de Vigilancia Epidemiológica y la red de los servicios de salud. Considerando que afectará a miles de personas, el objetivo de este artículo es describir las actuaciones realizadas y compartir los resultados y las lecciones aprendidas durante estos primeros meses con los ministerios de salud y los profesionales de los países de la Región para ayudarles a preparar una respuesta adecuada para afrontarla de forma efectiva y eficiente.


The chikungunya epidemic in the Dominican Republic began in February 2014. During the first six months 429 421 cases were recorded, representing 65% of all those notified to the Pan American Health Organization by 33 countries and territories of the Region of the Americas. This epidemic has spread quickly in the Dominican Republic, requiring a focused intersectoral response, led by the Ministry of Public Health and involving major efforts by the National Epidemiological System and the health services network. Given that the virus will affect thousands of people, this article seeks to describe the actions that have already been carried out, and to share the results and lessons learned during these first months with health ministries and professionals in the countries of the Region, in order to assist them to prepare an appropriate response to confront the epidemic effectively and efficiently.


Asunto(s)
Animales , Ratas , Núcleo Celular/metabolismo , Citoplasma/metabolismo , Proteínas HSP90 de Choque Térmico/metabolismo , Receptores de Glucocorticoides/metabolismo , Línea Celular , Dexametasona/farmacología , Haplorrinos , Riñón , Neoplasias Hepáticas Experimentales , Molibdeno/farmacología , Receptores de Glucocorticoides/genética , Transfección , Células Tumorales Cultivadas
3.
Clinics ; 69(3): 179-184, 3/2014. tab
Artículo en Inglés | LILACS | ID: lil-703600

RESUMEN

OBJECTIVES: We aimed to investigate whether glucocorticoid receptor gene polymorphisms are associated with clinical and metabolic profiles in patients with polycystic ovary syndrome. Polycystic ovary syndrome is a complex endocrine disease that affects 5-8% of women and may be associated with metabolic syndrome, which is a risk factor for cardiovascular disease. Cortisol action and dysregulation account for metabolic syndrome development in the general population. As glucocorticoid receptor gene (NR3C1) polymorphisms regulate cortisol sensitivity, we hypothesized that variants of this gene may be involved in the adverse metabolic profiles of patients with polycystic ovary syndrome. METHOD: Clinical, metabolic and hormonal profiles were evaluated in 97 patients with polycystic ovary syndrome who were diagnosed according to the Rotterdam criteria. The alleles of the glucocorticoid gene were genotyped. Association analyses were performed using the appropriate statistical tests. RESULTS: Obesity and metabolic syndrome were observed in 42.3% and 26.8% of patients, respectively. Body mass index was positively correlated with blood pressure, triglyceride, LDL-c, total cholesterol, glucose and insulin levels as well as HOMA-IR values and inversely correlated with HDL-c and SHBG levels. The BclI and A3669G variants were found in 24.7% and 13.4% of alleles, respectively. BclI carriers presented a lower frequency of insulin resistance compared with wild-type subjects. CONCLUSION: The BclI variant is associated with a lower frequency of insulin resistance in women with polycystic ovary syndrome. Glucocorticoid gene polymorphism screening during treatment of the syndrome may be useful for identifying subgroups of at-risk patients who would benefit the most from personalized treatment. .


Asunto(s)
Adulto , Femenino , Humanos , Adulto Joven , Síndrome del Ovario Poliquístico/genética , Síndrome del Ovario Poliquístico/metabolismo , Polimorfismo Genético/genética , Receptores de Glucocorticoides/genética , Alelos , Índice de Masa Corporal , Colesterol , Fluoroinmunoensayo , Frecuencia de los Genes , Genes bcl-1/genética , Hipertensión/genética , Hipertensión/metabolismo , Resistencia a la Insulina/genética , Síndrome Metabólico/genética , Síndrome Metabólico/metabolismo , Obesidad/genética , Obesidad/metabolismo , Reacción en Cadena de la Polimerasa , Factores de Riesgo , Estadísticas no Paramétricas , Factores de Tiempo
4.
Arq. bras. endocrinol. metab ; 58(1): 53-61, 02/2014. tab, graf
Artículo en Inglés | LILACS | ID: lil-705239

RESUMEN

Objective : The Brazilian population has heterogeneous ethnicity. No previous study evaluated NR3C1 polymorphisms in a Brazilian healthy population. Materials and methods : We assessed NR3C1 polymorphisms in Brazilians of Caucasian, African and Asian ancestry (n = 380). In a subgroup (n = 40), we compared the genotypes to glucocorticoid (GC) sensitivity, which was previously evaluated by plasma (PF) and salivary (SF) cortisol after dexamethasone (DEX) suppression tests, GC receptor binding affinity (K d ), and DEX-50% inhibition (IC 50 ) of concanavalin-A-stimulated mononuclear cell proliferation. p.N363S (rs6195), p.ER22/23EK (rs6189-6190), and BclI (rs41423247) allelic discrimination was performed by Real-Time PCR (Polymerase Chain Reaction). Exons 3 to 9 and exon/intron boundaries were amplified by PCR and sequenced. Results : Genotypic frequencies (%) were: rs6195 (n = 380; AA:96.6/AG:3.14/GG:0.26), rs6189-6190 (n = 264; GG:99.6/GA:0.4), rs41423247 (n = 264; CC:57.9/CG:34.1/GG:8.0), rs6188 (n = 155; GG:69.6/GT:25.7/TT:4.7), rs258751 (n = 150; CC:88.0/CT:10.7/TT:1.3), rs6196 (n = 176; TT:77.2/TC:20.4/CC:2.4), rs67300719 (n = 137; CC:99.3/CT:0.7), and rs72542757 (n = 137; CC:99.3/CG:0.7). The rs67300719 and rs72542757 were found only in Asian descendants, in whom p.N363S and p.ER22/23EK were absent. The p.ER22/23EK was observed exclusively in Caucasian descendants. Hardy-Weinberg equilibrium was observed, except in the Asian for rs6188 and rs258751, and in the African for p.N363S. The K d , IC 50 , baseline and after DEX PF or SF did not differ between genotype groups. However, the mean DEX dose that suppressed PF or SF differed among the BclI genotypes (P = 0.03). DEX dose was higher in GG- (0.7 ± 0.2 mg) compared to GC- (0.47 ± 0.2 mg) and CC-carriers (0.47 ± 0.1 mg). Conclusion : The genotypic frequencies of NR3C1 polymorphisms in Brazilians are similar to worldwide populations. Additionally, the BclI polymorphism ...


Objetivo : Este estudo avalia polimorfismos (SNPs) do NR3C1 na população brasileira, que possui origem étnica heterogênea. Materiais e métodos : SNPs do NR3C1 foram avaliados em brasileiros de ancestralidade caucasiana, africana ou japonesa (n = 380). Em um subgrupo (n = 40), os genótipos foram comparados à sensibilidade aos glicocorticoides (GC), previamente avaliada por cortisol plasmático (PF) e salivar (SF) após supressão com dexametasona (DEX), ensaio de afinidade do receptor ao GC (K d ) e inibição por DEX de 50% da proliferação de mononucleares estimulada por concanavalina-A (IC 50 ). Discriminação alélica de p.N363S (rs6195), p.ER22/23EK (rs6189-6190) e BclI (rs41423247) foi realizada por PCR em tempo real. Éxons 3 a 9 e transições éxon/íntron foram amplificados e sequenciados. Resultados : Frequências genotípicas (%) foram: rs6195 (n = 380; AA:96,6/AG:3,14/GG:0,26), rs6189-6190 (n = 264; GG:99,6/GA:0,4), rs41423247 (n = 264; CC:57,9/CG:34,1/GG:8,0), rs6188 (n = 155; GG:69,6/GT:25,7/TT:4,7), rs258751 (n = 150; CC:88,0/CT:10,7/TT:1,3), rs6196 (n = 176; TT:77,2/TC:20,4/CC:2,4), rs67300719 (n = 137; CC:99,3/CT:0,7), e rs72542757 (n = 137; CC:99,3/CG:0,7). Enquanto rs67300719 e rs72542757 foram exclusivos dos nipodescendentes, p.N363S e p.ER22/23EK estavam ausentes nesses indivíduos. p.ER22/23EK foi exclusivo dos descendentes de caucasianos. Equilíbrio de Hardy-Weinberg foi observado, exceto nos nipodescendentes para rs6188 e rs258751 e nos afrodescendentes para p.N363S. K d , IC 50 , PF ou SF basal ou após DEX foram semelhantes entre os genótipos. Entretanto, a dose média de DEX que suprimiu PF ou SF diferiu entre os genótipos BclI (P = 0,03), sendo maior nos carreadores GG (0,7 ± 0,2 mg) comparada aos GC (0,47 ± 0,2 mg) e CC (0,47 ± 0,1 mg). Conclusão : As ...


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Adulto Joven , Población Negra/genética , Pueblo Asiatico/genética , Población Blanca/genética , Errores Innatos del Metabolismo/genética , Polimorfismo Genético/efectos de los fármacos , Receptores de Glucocorticoides/deficiencia , Antiinflamatorios/farmacología , Brasil/etnología , Proliferación Celular/efectos de los fármacos , Dexametasona/farmacología , Frecuencia de los Genes , Estudios de Asociación Genética , Hidrocortisona/sangre , Hidrocortisona , Leucocitos Mononucleares/efectos de los fármacos , Polimorfismo de Nucleótido Simple , Receptores de Glucocorticoides/genética , Análisis de Secuencia de ADN
5.
Journal of Veterinary Science ; : 19-26, 2014.
Artículo en Inglés | WPRIM | ID: wpr-69674

RESUMEN

Type 1 diabetes is a common metabolic disorder accompanied by increased blood glucose levels along with glucocorticoid and cognitive deficits. The disease is also thought to be associated with environmental changes in brain and constantly induces oxidative stress in patients. Therefore, glucocorticoid-mediated negative feedback mechanisms involving the glucocorticoid receptor (GR) binding site are very important to understand the development of this disease. Many researchers have used streptozotocin (STZ)-treated diabetic animals to study changes in GR expression in the brain. However, few scientists have evaluated the hyperglycemic period following STZ exposure. In the present study, we found GR expression in the hippocampus varied based on the period after STZ administration for up to 4 weeks. We performed immunohistochemistry and Western blotting to validate the sequential alterations of GR expression in the hippocampus of STZ-treated type 1 diabetic rats. GR protein expression increased significantly until week 3 but decreased at week 4 following STZ administration. GR expression after 70 mg/kg STZ administration was highest at 3 weeks post-treatment and decreased thereafter. Although STZ-induced increase in GR expression in diabetic animals has been described, our data indicate that researchers should consider the sequential GR expression changes during the hyperglycemic period following STZ exposure.


Asunto(s)
Animales , Humanos , Masculino , Ratas , Diabetes Mellitus Experimental/inducido químicamente , Modelos Animales de Enfermedad , Regulación de la Expresión Génica , Hipocampo/metabolismo , Ratas Wistar , Receptores de Glucocorticoides/genética , Factores de Tiempo
6.
Clinics ; 68(5): 579-585, maio 2013. tab
Artículo en Inglés | LILACS | ID: lil-675761

RESUMEN

OBJECTIVES: Patients with Cushing's disease exhibit wide phenotypic variability in the severity of obesity, diabetes and hypertension. In the general population, several glucocorticoid receptor genes (NR3C1) and HSD11B1 polymorphisms are associated with altered glucocorticoid sensitivity and/or metabolism, resulting in an increased or reduced risk of an adverse metabolic profile. Our aim was to analyze the association of NR3C1 and HSD11B1 gene variants with the severity of some clinical and hormonal features of Cushing's disease. METHODS: Sixty-four patients presenting with Cushing's disease were diagnosed based on adrenocorticotrophic hormone levels, high-dose dexamethasone suppression tests and/or inferior petrosal sinus sampling and magnetic resonance imaging. The A3669G, ER22/23EK, N363S BclI-NR3C1 and HSD11B1-rs12086634 variants were screened. RESULTS: The BclI, HSD11B1-rs12086634 and A3669G variants were found in 36%, 19.5% and 14% of alleles, respectively. The N363S and ER22/23EK polymorphisms were identified in heterozygosis once in only two patients (1.5% of alleles). There were no differences in the weight gain or prevalence of diabetes and hypertension in the patients carrying the abovementioned alleles compared to the wild-type carriers. Interestingly, the mean body mass index (BMI) of the BclI carriers was significantly higher than the non-carriers (34.4±7 kg/m2 vs. 29.6±4.7 kg/m2, respectively). None of the polymorphisms were associated with the basal adrenocorticotrophic hormone, FU levels or F level after dexamethasone suppression testing. CONCLUSION: Although Cushing's disease results from increased glucocorticoid secretion, we observed that interindividual variability in the peripheral glucocorticoid sensitivity, mediated by the glucocorticoid receptor, could modulate the obesity phenotype. .


Asunto(s)
Femenino , Humanos , Masculino , Persona de Mediana Edad , Alelos , /genética , Predisposición Genética a la Enfermedad , Hipersecreción de la Hormona Adrenocorticotrópica Pituitaria (HACT)/genética , Polimorfismo Genético/genética , Receptores de Glucocorticoides/genética , Índice de Masa Corporal , Genotipo , Fenotipo , Hipersecreción de la Hormona Adrenocorticotrópica Pituitaria (HACT)/sangre
7.
West Indian med. j ; 61(9): 928-931, Dec. 2012.
Artículo en Inglés | LILACS | ID: lil-694369

RESUMEN

We report for the first time the case of a young man who developed both glucocorticoid resistance and resistance to parathyroid hormone. Treatment with high doses of dexamethasone together with administration of calcium and calcitriol resulted in a significant improvement in the patient's condition. In this paper, we discuss in detail diagnostic and treatment strategies used on the patient and the impact on the course and outcome of both disorders. We associate the development of both these disorders with a possible inherited defect in the signal pathways common to glucocorticoid and parathyroid hormone receptors.


Por primera vez se reporta el caso de un joven que desarrolló resistencia a glucocorticoides y resistencia a la hormona paratiroidea. El tratamiento con altas dosis de dexametasona, junto con la administración de calcio y calcitriol, trajo como resultado una mejoría significativa de la condición del paciente. En este papel, se analiza en detalle el diagnóstico así como las estrategias de tratamiento del paciente, y su impacto en el curso y resultado de ambos trastornos. Se concluye que el desarrollo de ambos trastornos se halla asociado a un posible defecto hereditario en las vías de transducción de señales comunes a los receptores de las hormonas glucocorticoides y las hormonas paratiroideas.


Asunto(s)
Adulto , Niño , Humanos , Masculino , Errores Innatos del Metabolismo/genética , Hormona Paratiroidea/administración & dosificación , Seudohipoparatiroidismo/diagnóstico , Calcitriol/administración & dosificación , Carbonato de Calcio/administración & dosificación , Dexametasona/administración & dosificación , Diagnóstico Diferencial , Resistencia a Medicamentos , Quimioterapia Combinada , Fenotipo , Seudohipoparatiroidismo/tratamiento farmacológico , Seudohipoparatiroidismo/genética , Receptores de Glucocorticoides/deficiencia , Receptores de Glucocorticoides/genética
8.
Medicina (B.Aires) ; 70(5): 457-462, oct. 2010. ilus
Artículo en Inglés | LILACS | ID: lil-633786

RESUMEN

This review highlights the most recent findings on the molecular mechanisms of the glucocorticoid receptor (GR). Most effects of glucocorticoids are mediated by the intracellular GR which is present in almost every tissue and controls transcriptional activation via direct and indirect mechanisms. Nevertheless the glucocorticoid responses are tissue -and gene- specific. GR associates selectively with corticosteroid ligands produced in the adrenal gland in response to changes of humoral homeostasis. Ligand interaction with GR promotes either GR binding to genomic glucocorticoid response elements, in turn modulating gene transcription, or interaction of GR monomers with other transcription factors activated by other signalling pathways leading to transrepression. The GR regulates a broad spectrum of physiological functions, including cell differentiation, metabolism and inflammatory responses. Thus, disruption or dysregulation of GR function will result in severe impairments in the maintenance of homeostasis and the control of adaptation to stress.


Esta revisión destaca los más recientes hallazgos sobre los mecanismos moleculares del receptor de glucocorticoides (GR). La mayoría de los efectos de los glucocorticoides son mediados por los GR intracelulares presentes en casi todos los tejidos y controlan la activación transcripcional por mecanismos directos e indirectos. Las respuestas a los glucocorticoides son específicas para cada gen y tejido. Los GR se asocian en forma selectiva con ligandos producidos en la glándula adrenal, corticosteroides, en respuesta a cambios neuroendocrinos. La interacción del ligando con el GR promueve: a) la unión del GR a elementos genómicos de respuesta a glucocorticoides, modulando la transcripción; b) la interacción de monómeros del GR con otros factores de transcripción activados por otras vías, llevando a la transrepresión. El GR regula un amplio espectro de funciones fisiológicas, incluyendo la diferenciación celular y las respuestas metabólicas e inflamatorias. Así, la desregulación de la función del GR resulta en graves defectos en el mantenimiento de la homeostasis y el control de la adaptación al estrés.


Asunto(s)
Humanos , Glucocorticoides/metabolismo , Receptores de Glucocorticoides/metabolismo , Transducción de Señal , Expresión Génica/fisiología , Glucocorticoides/genética , Receptores de Glucocorticoides/genética , Activación Transcripcional , Factores de Transcripción/metabolismo
9.
Mem. Inst. Oswaldo Cruz ; 104(4): 531-548, July 2009. ilus, tab
Artículo en Inglés | LILACS | ID: lil-523716

RESUMEN

Corticosteroids are widely used to treat a diversity of pathological conditions including allergic, autoimmune and some infectious diseases. These drugs have complex mechanisms of action involving both genomic and non-genomic mechanisms and interfere with different signal transduction pathways in the cell. The use of corticosteroids to treat critically ill patients with acute respiratory distress syndrome and severe infections, such as sepsis and pneumonia, is still a matter of intense debate in the scientific and medical community with evidence both for and against its use in these patients. Here, we review the basic molecular mechanisms important for corticosteroid action as well as current evidence for their use, or not, in septic patients. We also present an analysis of the reasons why this is still such a controversial point in the literature.


Asunto(s)
Humanos , Corticoesteroides/uso terapéutico , Receptores de Glucocorticoides/efectos de los fármacos , Síndrome de Dificultad Respiratoria/tratamiento farmacológico , Choque Séptico/tratamiento farmacológico , Ensayos Clínicos como Asunto , Medicina Basada en la Evidencia , Genómica , Inmunidad Innata/efectos de los fármacos , Inmunidad Innata/genética , Chaperonas Moleculares/efectos de los fármacos , Chaperonas Moleculares/genética , Receptores de Glucocorticoides/genética , Activación Transcripcional/efectos de los fármacos , Activación Transcripcional/genética
10.
Arq. bras. endocrinol. metab ; 53(2): 288-292, Mar. 2009. tab
Artículo en Inglés | LILACS | ID: lil-513784

RESUMEN

OBJECTIVE: To verify whether N363S polymorphism of the glucocorticoid receptor-gene can be associated to visceral fat by CT scan in obese individuals, and the impact of this variant on metabolic profile. METHODS: The N363S variant was screened in 295 Brazilians, 195 were obese and 100 presented normal weight. Based on genotype, obese N363S SNP carriers were paired with obese wild-type subjects. This group was submitted to a CT scan and metabolic profile assessment. RESULTS: Ten subjects were found to be heterozygous for the variant (A/G genotype frequency 3.4 percent), 8 (4.1 percent) obese and 2 (2.0 percent) non-obese. No differences were reported for visceral adiposity area (145.8 ± 49.9 vs.147.7 ± 48.8 cm²; p = 0.92) based on CT scan results but N363S SNP carriers showed a proneness to unfavorable metabolic changes. CONCLUSION: The N363S polymorphism prevalence is low in the Brazilian population, although its presence may contribute to the worsening of individuals' metabolic profiles.


OBJETIVO: Verificar se a presença do polimorfismo N363S do gene do receptor de glucocorticoide estaria associada, em indivíduos obesos, à presença de adiposidade visceral pela tomografia computadorizada, e sobre o impacto desta variante genética no perfil metabólico. MÉTODOS: A variante N363S do receptor do glicocorticoide foi verificada em um grupo de 295 indivíduos brasileiros, sendo 295 obesos e 100 com peso normal. Com base na genotipagem, os indivíduos obesos carreadores do polimorfismo N363S foram pareados com obesos normais. O grupo com polimorfismo foi submetido a exames de tomografia computadorizada abdominal e laboratoriais para a caracterização de seu perfil metabólico. RESULTADOS: Dez indivíduos eram heterozigotos para a variante AG (3,4 por cento), sendo oito obesos (4,1 por cento) e dois não-obesos (2 por cento). Não foram encontradas diferenças na quantidade de adiposidade visceral (145,8 ± 49,9 versus 147,7 ± 48,8 cm²; p = 0,92) baseados no TC de abdômen. No entanto, os indivíduos carreadores do N363S SNP (single nucleotide polymorphism) apresentaram tendência a perfil metabólico desfavorável. CONCLUSÃO: O polimorfismo N363S do gene do receptor de glucocorticoide teve prevalência baixa na população estudada. A sua presença pode contribuir para a deterioração do perfil metabólico desses indivíduos.


Asunto(s)
Adolescente , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Grasa Intraabdominal/anatomía & histología , Polimorfismo Genético , Receptores de Glucocorticoides/genética , Índice de Masa Corporal , Brasil , Presión Sanguínea/fisiología , Colesterol/sangre , Heterocigoto , Resistencia a la Insulina/genética , Grasa Intraabdominal/metabolismo , Grasa Intraabdominal , Obesidad/genética , Tomografía Computarizada por Rayos X , Adulto Joven
11.
Arq. bras. endocrinol. metab ; 53(1): 24-30, fev. 2009. graf, tab
Artículo en Inglés | LILACS | ID: lil-509862

RESUMEN

OBJECTIVES: To analyze glucocorticoid (GC) sensitivity using intravenous very low dose dexamethasone suppression test (IV-VLD-DST) in patients with rheumatoid arthritis (RA) and its correlation with glucocorticoid receptor alpha-isoform (GRα) gene expression. METHODS: We evaluated 20 healthy controls and 32 RA patients with Health Assessment Questionnaire (HAQ) and Disease Activity Score 28 joints (DAS) scores and IV-VLD-DST and GRα expression in mononuclear cells. RESULTS: Basal cortisol and the percentage of cortisol reduction after IV-VLD-DST were lower in RA patients than in controls, whereas GRα expression was similar among groups. In the RA group there was an inverse correlation between GRα expression and the percentage of cortisol suppression that was not observed in controls. There was a direct relationship between DAS and GRα expression. CONCLUSIONS: Mechanisms involved in GC resistance observed in patients with RA are possibly not at the level of GRα gene expression, since it was similar among groups and GRα increased with disease activity.


OBJETIVOS: Determinar a sensibilidade aos glicocorticóides (GC) utilizando teste de supressão com dexametasona em doses muito baixas (IV-VLD-DST) em pacientes com artrite reumatóide (AR) e sua correlação com a expressão gênica da isoforma alfa do receptor glicocorticóide (GRα). MÉTODOS: Foram avaliados 20 controles saudáveis e 32 pacientes com AR com Health Assessment Questionnaire (HAQ) e Disease Activity Score 28 joints (DAS), IV-VLD-DST e expressão do GRα em células mononucleares. RESULTADOS: Cortisol basal e porcentagem de redução do cortisol após IV-VLD-DST foram menores no grupo AR do que nos controles, enquanto a expressão de GRα foi similar entre eles. No grupo com AR, ocorreu correlação negativa entre a expressão do GRα e a porcentagem de supressão do cortisol, enquanto nos controles não houve correlação. Ocorreu relação direta entre DAS e expressão de GRα . CONCLUSÕES: Sugerimos que os mecanismos envolvidos na resistência aos GC observada na AR não estejam ao nível da expressão gênica do GRα, já que esta é igual entre os grupos e aumenta com a gravidade da doença.


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Artritis Reumatoide , Dexametasona/farmacología , Resistencia a Medicamentos/fisiología , Glucocorticoides/farmacología , Receptores de Glucocorticoides , Análisis de Varianza , Artritis Reumatoide/tratamiento farmacológico , Artritis Reumatoide/genética , Estudios de Casos y Controles , Hidrocortisona/sangre , Receptores de Glucocorticoides/efectos de los fármacos , Receptores de Glucocorticoides/genética
12.
Experimental & Molecular Medicine ; : 297-306, 2009.
Artículo en Inglés | WPRIM | ID: wpr-136595

RESUMEN

Increased expression of a number of proinflammatory genes, including IL-8, is associated with inflammatory conditions such as asthma. Glucocorticoid receptor (GR)beta, one of the GR isoforms, has been suggested to be upregulated in asthma associated with glucocorticoid insensitivity and to work as a dominant negative inhibitor of wild type GRalpha. However, recent data suggest that GRbeta is not a dominant negative inhibitor of GRalpha in the transrepressive process and has its own functional role. We investigated the functional role of GRbeta expression in the suppressive effect of glucocorticoids on tumor necrosis factor (TNF)-alpha-induced IL-8 release in an airway epithelial cell line. GRbeta expression was induced by treatment of epithelial cells with either dexamethasone or TNF-alpha. GRbeta was able to inhibit glucocorticoid-induced transcriptional activation mediated by binding to glucocorticoid response elements (GREs). The suppressive effect of dexamethasone on TNF-alpha-induced IL-8 transcription was not affected by GRbeta overexpression, rather GRbeta had its own weak suppressive activity on TNF-alpha-induced IL-8 expression. Overall histone deacetylase activity and histone acetyltransferase activity were not changed by GRbeta overexpression, but TNF-alpha-induced histone H4 acetylation at the IL-8 promoter was decreased with GRbeta overexpression. This study suggests that GRbeta overexpression does not affect glucocorticoid-induced suppression of IL-8 expression in airway epithelial cells and GRbeta induces its own histone deacetylase activity around IL-8 promoter site.


Asunto(s)
Humanos , Acetilación , Línea Celular Tumoral , Dexametasona/farmacología , Células Epiteliales/metabolismo , Regulación de la Expresión Génica , Histonas/metabolismo , Interleucina-8/genética , Receptores de Glucocorticoides/genética , Activación Transcripcional , Transfección , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores
13.
Experimental & Molecular Medicine ; : 297-306, 2009.
Artículo en Inglés | WPRIM | ID: wpr-136594

RESUMEN

Increased expression of a number of proinflammatory genes, including IL-8, is associated with inflammatory conditions such as asthma. Glucocorticoid receptor (GR)beta, one of the GR isoforms, has been suggested to be upregulated in asthma associated with glucocorticoid insensitivity and to work as a dominant negative inhibitor of wild type GRalpha. However, recent data suggest that GRbeta is not a dominant negative inhibitor of GRalpha in the transrepressive process and has its own functional role. We investigated the functional role of GRbeta expression in the suppressive effect of glucocorticoids on tumor necrosis factor (TNF)-alpha-induced IL-8 release in an airway epithelial cell line. GRbeta expression was induced by treatment of epithelial cells with either dexamethasone or TNF-alpha. GRbeta was able to inhibit glucocorticoid-induced transcriptional activation mediated by binding to glucocorticoid response elements (GREs). The suppressive effect of dexamethasone on TNF-alpha-induced IL-8 transcription was not affected by GRbeta overexpression, rather GRbeta had its own weak suppressive activity on TNF-alpha-induced IL-8 expression. Overall histone deacetylase activity and histone acetyltransferase activity were not changed by GRbeta overexpression, but TNF-alpha-induced histone H4 acetylation at the IL-8 promoter was decreased with GRbeta overexpression. This study suggests that GRbeta overexpression does not affect glucocorticoid-induced suppression of IL-8 expression in airway epithelial cells and GRbeta induces its own histone deacetylase activity around IL-8 promoter site.


Asunto(s)
Humanos , Acetilación , Línea Celular Tumoral , Dexametasona/farmacología , Células Epiteliales/metabolismo , Regulación de la Expresión Génica , Histonas/metabolismo , Interleucina-8/genética , Receptores de Glucocorticoides/genética , Activación Transcripcional , Transfección , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores
14.
Arq. bras. endocrinol. metab ; 50(6): 983-995, dez. 2006. ilus
Artículo en Portugués, Inglés | LILACS | ID: lil-439716

RESUMEN

Os glicocorticóides exercem um papel importante na regulação fisiológica e na adaptação a situações de stress, sendo a maioria dos efeitos destes hormônios mediada pela interação com os receptores glicocorticóides. A sensibilidade ao glicocorticóide depende da densidade celular de receptores expressos, bem como da eficiência da transdução do sinal mediada pelo complexo hormônio-receptor. Os estados de resistência ou de hipersensibilidade ao glicocorticóide, observados, respectivamente, nas doenças inflamatórias auto-imunes e na síndrome metabólica, podem representar a variabilidade dos fatores que influenciam a cascata de sinalização do glicocorticóide. O reconhecimento destes fatores contribui para uma melhor compreensão tanto do fenótipo clínico e da evolução destas doenças quanto da resposta terapêutica com glicocorticóide. A compreensão destes mecanismos fisiopatológicos também pode contribuir para a escolha de intervenções terapêuticas. Neste artigo de revisão, descrevemos os múltiplos fatores envolvidos nesta cascata de sinalização, os quais são capazes de influenciar a sensibilidade ao glicocorticóide.


Glucocorticoids play an essential role in maintaining basal and stress-related homeostasis. Most known effects of glucocorticoids are mediated by the intracellular glucocorticoid receptors. The glucocorticoid sensitivity seems to depend on the amount of receptors expressed and the efficiency of glucocorticoid receptor-mediated signal transduction. Glucocorticoid resistance or hypersensitivity, seen in autoimmune-inflammatory diseases and in metabolic syndrome respectively, can represent the variability of several steps that influence the signaling cascade of glucocorticoid action. The recognition of these steps could provide the understanding of the clinical phenotype and course of such diseases as well as their responsiveness to glucocorticoid therapy. The comprehension of these pathophysiological mechanisms can also improve the possible therapeutic interventions. In this review, we have summarized the multiple factors that have been shown to be involved in this signaling cascade and, thus, to influence glucocorticoid sensitivity.


Asunto(s)
Humanos , Enfermedades Autoinmunes/fisiopatología , Glucocorticoides/fisiología , Hipersensibilidad/fisiopatología , Síndrome Metabólico/fisiopatología , Receptores de Glucocorticoides/fisiología , Transducción de Señal/fisiología , Antiinflamatorios/farmacología , Proliferación Celular/efectos de los fármacos , Dexametasona/farmacología , Glucocorticoides/metabolismo , Glucocorticoides/uso terapéutico , Hipersensibilidad/metabolismo , Inflamación/fisiopatología , Receptores de Glucocorticoides/genética , Receptores de Glucocorticoides/metabolismo , Transducción de Señal/efectos de los fármacos
15.
Journal of Huazhong University of Science and Technology (Medical Sciences) ; (6): 28-30, 2006.
Artículo en Inglés | WPRIM | ID: wpr-634300

RESUMEN

Human monocyte leukemia cell line THP-1 was stimulated with lipopolysaccharide (LPS) to simulate the sepsis model and the expression of human glucocorticoid receptor-alpha (GR-alpha) mRNA in montocytes with endotoxin tolerance was investigated. THP-1 cells were cultured in serum-free medium, randomly divided into groups A, B, C, D and E, and stimulated with 0, 10, 10, 100, 0 ng/mL LPS for 24 h followed with 100, 100, 10, 100, 0 ng/mL LPS for another 24 h respectively. The expression of GR-alpha mRNA was detected by semi-quantitative reverse transcriptional polymerase chain reaction. Tumor necrosis factor-alpha (TNF-alpha) was determined by enzyme linked immunosorbent assay (ELISA). The results showed that the A values of GR-alpha/beta-actin in groups A, B, C, D and E was 0.607 +/- 0.006, 0.368 +/- 0.005, 0.484 +/- 0.008, 0.509 +/- 0.004 and 0.564 +/- 0.014 respectively with the difference being significant among the groups (P < 0.05). The GR-alpha mRNA expression was negatively correlated with the TNF-alpha expression (P < 0.01). It was concluded that the down-regulation of the expression of GR-alpha mRNA in endotoxin tolerance THP-1 cells might play an important role in the development of endotoxin tolerance in THP-1 cells.


Asunto(s)
Tolerancia a Medicamentos , Endotoxinas/farmacología , Leucemia Monocítica Aguda/metabolismo , Leucemia Monocítica Aguda/patología , Monocitos/metabolismo , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Receptores de Glucocorticoides/biosíntesis , Receptores de Glucocorticoides/genética , Células Tumorales Cultivadas
16.
The Korean Journal of Gastroenterology ; : 103-110, 2005.
Artículo en Coreano | WPRIM | ID: wpr-84687

RESUMEN

BACKGROUND/AIMS: Glucocorticoid resistance poses a challenging clinical problem in inflammatory bowel disease because more than one fourth of patients with severe ulcerative colitis do not respond to anti-inflammatory steroids. Recently, it has been reported that glucocorticoid response is related to the expression of human glucocorticoid receptor beta (hGRbeta) and nuclear factor-kappa B (NF-kappaB) activity. The aims of this study were to clarify whether these factors may predict the responsiveness before treatment. METHODS: Total RNA was extracted from peripheral blood mononuclear cell (PBMC) and colonic mucosa in 17 patients of ulcerative colitis before steroid administration. RNA was reverse transcribed and the resulting complementary DNA was amplified using specific primers for hGR alpha and beta. Concomitantly, NF-kappaB activity in colonic mucosa was assessed by immunohistochemical stain. RESULTS: The expression of hGRbeta mRNA was detected in 10 patients (58.8%) in PBMC and 8 patients (47.1%) in colon, respectively. Operations were performed in 5 patients due to steroid unresponsiveness. Only 5 of 17 patients (29.4%) were consistent in the expression of hGRbeta between PBMC and colon. Seven of 15 patients (46.7%) showed an alteration in the expression of hGRbeta in PBMC after glucocorticoid treatment. NF-kappaB activity was found in both epithelial cell and lamina propria in 12, epithelial cell alone in 1, lamina propria alone in 1 and all negative in 3 patients, respectively. CONCLUSIONS: The expression of hGRbeta was discordant between PBMC and colon in the same patient and showed a change in the expession after the glucocorticoid treatment in nearly half. The expression of hGRbeta and colonic NF-kappaB activity patterns do not provide useful information about glucocorticoid response in patients with ulcerative colitis.


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Colitis Ulcerosa/metabolismo , Colon/metabolismo , Expresión Génica , Inmunohistoquímica , Mucosa Intestinal/metabolismo , Leucocitos Mononucleares/metabolismo , FN-kappa B/metabolismo , ARN Mensajero/metabolismo , Receptores de Glucocorticoides/genética
17.
São Paulo; s.n; São Paulo. [120] p. ilus, tab, graf.
Tesis en Portugués | LILACS | ID: lil-397914

RESUMEN

Analisamos a prevalência do polimorfismo N363S do gene do receptor de glicocorticóide em uma população brasileira, e verificamos o efeito desta variante na sensibilidade aos glicocorticóides, na distribuição de gordura corporal e nas alterações metabólicas. Avaliamos 295 indivíduos, 195 obesos e 100 com peso normal. Identificamos 10 (3,4 por cento) portadores do polimorfismo, 8 (4,1 per cent) entre obesos e 2 (2,0 por cento) entre os de peso normal. Não houve diferenças na resposta de cortisol, glicemia, insulina e leptina à dexametasona entre os portadores e não portadores. Não houve diferença na área de gordura visceral (AV) mensurada pela tomografia computadorizada. Houve uma tendência a maiores escores de HOMA-IR, maiores níveis de pressão arterial sistólica e menores níveis de HDL-colesterol nos portadores do polimorfismo./The aim of the present study is to assess the prevalence of N363S polymorphism in a brazilian population, as well as to look into the effects of this variant on glucocorticoid sensitivity in body adiposity and in metabolic changes. A total of 295 individuals have been assessed, 195 obese and 100 normal weight. Our study identified 10(3.4 per cent) polymorphism carriers, 8(4.1 per cent) among obese, and 2 (2.0 per cent) among normal body weight individuals. No differences were reported for cortisol response, glycemia, insulin, and leptin at 0.25mg and 1 mg dexamethasone doses. No differences were reported for visceral adiposity (VA) either, based on CT-scan results. A tendency was shown for higher HOMA-IR scores, higher systolic blood pressure levels and lower levels of HDL-cholesterol in polymorphism carriers...


Asunto(s)
Humanos , Masculino , Femenino , Embarazo , Adolescente , Adulto , Persona de Mediana Edad , Obesidad/genética , Receptores de Glucocorticoides/genética , Obesidad/fisiopatología , Receptores de Glucocorticoides/metabolismo , Síndrome Metabólico/fisiopatología
18.
Arq. bras. endocrinol. metab ; 42(5): 351-6, out. 1998. ilus, tab
Artículo en Portugués | LILACS | ID: lil-262197

RESUMEN

O gene humano do receptor de glicocorticóide (hRG) apresenta duas isoformas, a clássica alpha e a beta, produzidas por um "splicing" alternativo de um único gene, no cromossomo 5. Estas isoformas possuem os primeiros oito exons em comum, diferindo no exon 9. Esta diferença torna a isoforma beta incapaz de ligar-se aos glicocorticóides e de ativar a transcrição dos genes responsivos a eles. A isoforma beta é um inibidor dominante negativo da isoforma alpha e regula a sensibilidade endógena aos glicocorticóides. A síndrome de resistência generalizada aos glicocorticóides caracteriza-se pela hipossensibilidade de todos os tecidos do organismo ao cortisol. A retroalimentação negativa ao nível do eixo hipotálamo-hipofisário encontra-se comprometida, resultando em elevadas concentrações de ACTH, com conseqüente elevação do cortisol, hipersecreção de mineralocorticóides e andrógenos. As manifestações clínicas variam desde pacientes assintomáticos ou com queixas sutis de fadiga crônica até hipertensão e alcalose hipocalêmica, secundárias ao hipermineralocorticismo, virilização na mulher (acne, hirsutismo, oligomenorréia, oligo-anovulação e infertilidade), adrenarca precoce na criança e alterações na espermatogênese no homem, secundários ao hiperandrogenismo. Estudos funcionais dos RGs demonstram diminuição da afinidade ou do número deste receptores. Diferentes alterações moleculares como mutações puntiformes e microdeleções, com conseqüente redução da expressão da proteína do RG ou da afinidade dos RG, têm sido descritas e parecem causar resistência aos glicocorticóides. O tratamento requer a administração de doses elevadas de glicocorticóides para suprimir a hipersecreção de ACTH, diminuindo, conseqüentemente, a secreção de cortisol, mineralocorticóides e andrógenos.


Asunto(s)
Humanos , Glucocorticoides/farmacología , Receptores de Glucocorticoides/genética , Resistencia a Medicamentos/genética , Síndrome
19.
Medicina (B.Aires) ; 57(1): 75-80, ene.-feb. 1997. ilus
Artículo en Español | LILACS | ID: lil-199735

RESUMEN

Hemos demostrado previamente que el TNF-alpha y la IL-1 aumentan la actividad transcripcional del receptor de glucocorticoides (GR) inducida por glucocorticoides (GC) en distintas líneas celulares transfectadas con un plásmido reporter llevando elementos respondedores a GC (GRE). En células blanco de TNF-alpha y GC determinamos: 1) TNF-alpha aumentó el N de GR en células L-929 y 2) por transfección de las mismas con un plásmido reporter llevando el promotor de GR que este efecto es a nivel transcripcional, 3) por ensayos de movilidad electroforética utilizando extractos nucleares de células L-929 estimuladas con TNF-alpha 0,02 ng/ml, DEX 10 nM o TNF-alpha + DEX, que las citoquinas aumentan la unión de GR a GRE (45 min, 1,8 x), mientras que la expresión del factor NF(k)B inducido por TNF-alpha no fue afectada por GC, 4) como correlato biológico de estos mecanismos, un priming de TNF-alpha (no citotóxico) aumentó la sensibilidad a la protección por GC de la apoptosis inducida por esta citoquina (p < 0.001). El organismo se protege de una respuesta inmune exacerbada, no sólo por un aumento de GC por citoquinas, sino también, aumentando la sensibilidad a los mismos: vía un aumento en el N de GR, en el binding a GRE y de la transcripción de sus genes blanco (ej. genes protectores de la apoptosis inducida por TNF-alpha). Estos mecanismos contribuyen a aumentar la actividad antiinflamatoria e inmunosupresora de GC para mantener la homeostasis.


Asunto(s)
Citocinas/inmunología , Glucocorticoides/genética , Interleucina-1/farmacología , Receptores de Glucocorticoides/genética , Factor de Necrosis Tumoral alfa/farmacología , Apoptosis/efectos de los fármacos , Citocinas/farmacología , Glucocorticoides/inmunología , Homeostasis , Inmunidad/efectos de los fármacos , Receptores de Glucocorticoides/inmunología , Transcripción Genética , Transfección
20.
Indian J Biochem Biophys ; 1988 Oct; 25(5): 377-84
Artículo en Inglés | IMSEAR | ID: sea-27342
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA